Alvaro Gutierrez
Neurology · Morgantown, WVNPI 1457457723
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.4% of the total across 91 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 16.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,051 and has fallen 87.0% since, to $136 in 2025.
Across 91 payments — averaging $18.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$283
- Regeneron Healthcare Solutions, Inc.$240
- Novartis$192
- Acadia Pharmaceuticals Inc$130
- Acorda Therapeutics, Inc$128
- Lilly USA, LLC$127
- plus $590 from 17 others
What the payments were for
- Speaking & faculty fees$1288%
- Food & beverage$1,56192%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 12 | $283 |
| Regeneron Healthcare Solutions, Inc. | 2 | $240 |
| Novartis | 14 | $192 |
| Acadia Pharmaceuticals Inc | 3 | $130 |
| Acorda Therapeutics, Inc | 7 | $128 |
| Lilly USA, LLC | 9 | $127 |
| EMD Serono, Inc. | 5 | $68 |
| Sunovion Pharmaceuticals Inc. | 7 | $66 |
| AbbVie(2 entities) | 5 | $66 |
| Amgen | 5 | $61 |
| Genentech USA, Inc. | 3 | $55 |
| Greenwich Biosciences, Inc. | 3 | $48 |
| Lundbeck LLC | 3 | $45 |
| Amneal Pharmaceuticals LLC | 2 | $38 |
| Livanova USA, Inc. | 2 | $28 |
| Strongbridge US Inc. | 2 | $24 |
| Bausch Health US, LLC | 1 | $16 |
| Aquestive Therapeutics, Inc. | 1 | $14 |
| Biogen | 1 | $14 |
| MDD US Operations, LLC | 1 | $13 |
| Tanabe Pharma America, Inc. | 1 | $12 |
| UCB, Inc. | 1 | $11 |
| GE HealthCare | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Austedo XR$122
- DUPIXENT$118
- NUPLAZID$101
How this compares
$1,689 in reported general payments places this provider in the 55th percentile of 93 neurology providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NuplazidPimavanserin Tartrate | 34 | $182,298 |
| EliquisApixaban | 271 | $167,493 |
| IngrezzaValbenazine Tosylate | 20 | $167,268 |
| RytaryCarbidopa/Levodopa | 270 | $148,726 |
| AustedoDeutetrabenazine | 11 | $144,122 |
| Avonex Pen (4 Pack)Interferon Beta-1a | 12 | $105,790 |
| Emgality SyringeGalcanezumab-Gnlm | 108 | $91,916 |
| NeuproRotigotine | 76 | $67,507 |
| XareltoRivaroxaban | 88 | $45,852 |
| GocovriAmantadine Hcl | 18 | $43,007 |
| Aimovig AutoinjectorErenumab-Aooe | 42 | $33,964 |
| Emgality PenGalcanezumab-Gnlm | 37 | $29,328 |
| Carbidopa-Levodopa-EntacaponeCarbidopa/Levodopa/Entacapone | 321 | $20,381 |
| NuedextaDextromethorphan Hbr/Quinidine | 12 | $19,881 |
| BrilintaTicagrelor | 30 | $14,199 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Acadia Pharmaceuticals IncNuplazid | $130 | $182,29834 claims |
| Amneal Pharmaceuticals LLCRytary, Pyridostigmine Bromide | $38 | $150,090382 claims |
| Teva Pharmaceuticals USA, Inc.Austedo | $283 | $144,12211 claims |
| UCB, Inc.Neupro | $11 | $67,50776 claims |
| MDD US Operations, LLCGocovri | $13 | $43,00718 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 93 neurology providers in West Virginia.
Other neurology in Morgantown
- Umer NajibMorgantown$246K
- Cheryl SmithMorgantown$68K
- Mouhannad AzzouzMorgantown$40K
- Maria Moreno EscobarMorgantown$23K
- Shumaila SultanMorgantown$13K
- Ann MurrayMorgantown$12K
- Violina MelnicMorgantown$12K
- Melanie WardMorgantown$9K
- Richa TripathiMorgantown$8K
- Phong VuMorgantown$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.